# Drug Use Investigation of COMIRNATY Intramuscular Injection

> **NCT04815031** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 14570 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** BNT162b2

## Key facts

- **NCT ID:** NCT04815031
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-20
- **Primary completion:** 2023-01-27
- **Final completion:** 2023-01-27
- **Target enrollment:** 14570 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815031, "Drug Use Investigation of COMIRNATY Intramuscular Injection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04815031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*